James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology. James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology. | | |
|
The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question. The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question. | | |
|
Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes. Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes. | | |
|
The global medtech company is also looking to expand its organ transplant and ECMO portfolios. The global medtech company is also looking to expand its organ transplant and ECMO portfolios. | | |
|
|
Sotagliflozin, a dual SGLTI and SGLT2 inhibitor, can significantly reduce the risk of adverse cardiovascular events in patients with type 2 diabetes, CKD and additional cardiovascular risk factors, according to a new study of more than 10,000 patients. Sotagliflozin, a dual SGLTI and SGLT2 inhibitor, can significantly reduce the risk of adverse cardiovascular events in patients with type 2 diabetes, CKD and additional cardiovascular risk factors, according to a new study of more than 10,000 patients. | | |
|
The median follow-up period was more than nine years, allowing researchers to compare long-term outcomes after both CABG and PCI. The median follow-up period was more than nine years, allowing researchers to compare long-term outcomes after both CABG and PCI. | | |
|
Aspartame, the artificial sweetener commonly found in diet sodas and sugar-free snacks, may do significant harm to a person’s cardiovascular system. Aspartame, the artificial sweetener commonly found in diet sodas and sugar-free snacks, may do significant harm to a person’s cardiovascular system. | | |
|
|
Smartphones have made it easier than ever for patients to monitor their own health, but the technology is far from infallible. Smartphones have made it easier than ever for patients to monitor their own health, but the technology is far from infallible. | | |
|
Many heart failure patients still skip cardiac rehab altogether. Offering a home-based option could potentially help reverse that trend. Many heart failure patients still skip cardiac rehab altogether. Offering a home-based option could potentially help reverse that trend. | | |
|
A Tulsa-based cardiology clinic was accused of submitting false claims for E&M services over a period of several years. A Tulsa-based cardiology clinic was accused of submitting false claims for E&M services over a period of several years. | | |
|
|
Healthcare consumers are wary of healthcare systems packing AI. Healthcare consumers are wary of healthcare systems packing AI. | | |
|
Following the mass layoffs, labeled “the Valentine’s Day Massacre” by some, many have expressed concern with how the move could impact patient care, AI research and more. Following the mass layoffs, labeled “the Valentine’s Day Massacre” by some, many have expressed concern with how the move could impact patient care, AI research and more. | | |
|
